Extraction and purification of hepatitis B virus-like M particles from a recombinant Saccharomyces cerevisiae strain using alumina powder

Journal of Virological Methods

Volumn 187, Issue 1, 2013, Pages 132-137

  Hadiji Abbes, Nadia ^a   Martin, Marta ^b   Benzina, Wafa ^b   Karray Hakim, Hella ^a   Gergely, Csilla ^b   Gargouri, Ali ^a   Mokdad Gargouri, Raja ^a  

^a UNIVERSITY OF SFAX   (Tunisia)

^b UNIVERSITÉ MONTPELLIER 2   (France)

Author keywords

Atomic force microscopy; Hepatitis B virus; Recombinant M protein Saccharomyces cerevisiae; Virus like particle

Indexed keywords

ALUMINUM OXIDE; GLASS; HEPATITIS B ANTIBODY; M PROTEIN;

ARTICLE; ATOMIC FORCE MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL FILTRATION; GEL PERMEATION CHROMATOGRAPHY; HEPATITIS B; HEPATITIS B VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN PURIFICATION; QUANTITATIVE ANALYSIS; SACCHAROMYCES CEREVISIAE; VIRUS ISOLATION; VIRUS LIKE AGENT; VIRUS PURIFICATION; YEAST CELL;

ALUMINUM OXIDE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MICROSCOPY, ATOMIC FORCE; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE;

HEPATITIS B VIRUS; SACCHAROMYCES CEREVISIAE;

EID: 84871731039     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.09.023     Document Type: Article

References (32)

1. Bardiya N. Expression in and purification of Hepatitis B surface antigen (S-protein) from methylotrophic yeast Pichia pastoris. Anaerobe 2006, 12:194-203.
2. Borchani-Chabchoub I., Mokdad-Gargouri R., Gargouri A. Glucose dependant negative translational control of the heterologous expression of the preS2 HBV antigen in yeast. Gene 2003, 311:165-170.
3. Cereghino G.P., Cregg J.M. Applications of yeast in biotechnology: protein production and genetic analysis. Curr. Opin. Biotechnol. 1999, 10:422-427.
4. Cregg J.M., Tschopp J.F., Stillman C., Siegel R., Akong M., Craig W.S., Buckholz R.G., Madden K.R., Kellaris P.A., Davis G.R., Smiley B.L., Cruze J., Torregrossa R., Velicelibi G., Thill G.P. High level expression and efficient assembly of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris. Biotechnology 1987, 5:479-485.
5. Deng Q., Kong Y.Y., Xie Y.H., Wang Y. Expression and purification of the complete PreS region of hepatitis B virus. World J. Gastroenterol. 2005, 28:3060-3064.
6. Ferrari C., Penna A., Bertoletti A., Cavalli A., Valli A., Schianchi C., Fiaccadori F. The pre-S1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man. J. Clin. Invest. 1989, 84:1314-1319.
7. Frederix P.L., Bosshart P.D., Engel A. Atomic force microscopy of biological membranes. Biophys. J. 2009, 96:329-338.
8. Gerlich W.H., Deepen R., Heermann K.H., Krone B., Lu X.Y., Seifer M., Thomssen R. Protective potential of hepatitis B virus antigens other than the S gene protein. Vaccine 1990, 8(Suppl.):S63-S68.
9. Giocondi M.C., Yamamoto D., Lesniewska E., Milhiet P.E., Ando T., Le Grimellec C. Surface topography of membrane domains. Biochim. Biophys. Acta 2010, 1798:703-718.
10. Hadiji-Abbes N., Borchani-Chabchoub I., Triki H., Ellouz R., Gargouri A., Mokdad-Gargouri R. Expression of HBsAg and preS2-S protein in different yeast based system: a comparative analysis. Protein Expr. Purif. 2009, 66:131-137.
11. Holzer G.W., Mayrhofer J., Leitner J., Blum M., Webersinke G., Heuritsch S., Falkner F.G. Overexpression of hepatitis B virus surface antigens including the preS1 region in a serum-free Chinese hamster ovary cell line. Protein Expr. Purif. 2003, 29:58-69.
12. Huang Y., Bi J., Zhang Y., Zhou W., Li Y., Zhao L., Su Z. A highly efficient integrated chromatographic procedure for the purification of recombinant hepatitis B surface antigen from Hansenula polymorpha. Protein Expr. Purif. 2007, 56:301-310.
13. Hu B., Liang M., Hong G., Li Z., Zhu Z., Li L. Expression of Hepatitis B virus S gene in Pichia pastoris and application of the product for detection of anti-HBs antibody. J. Biochem. Mol. Biol. 2005, 38:683-689.
14. Kuroda S., Fujisawa Y., Iino S., Akahana Y., Suzuki H. Induction of protection level of anti-pres2 antibodies in humans immunized with a novel hepatitis B vaccine consisting of M (preS2-S) protein particles (a third generation vaccine). Vaccine 1991, 9:163-169.
15. Kuroda S., Otaka S., Miyazaki T., Nakao M., Fujisawa Y. Hepatitis B virus envelope L protein particles, synthesis and assembly in Saccharomyces cerevisiae, purification and characterization. J. Biol. Chem. 1992, 26:1953-1961.
16. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepatitis 2004, 11:97-107.
17. Li J.H., Sun X.M., Zhang Y.X. Improvement of hepatitis B surface antigen expression by dimethyl sulfoxide in the culture of recombinant Chinese hamster ovary cells. Process. Biochem. 2006, 41:317-322.
18. Liu R., Lin Q., Sun Y., Lu X., Qiu Y., Li Y., Guo X. Expression, purification, and characterization of hepatitis B virus surface antigens (HBsAg) in yeast Pichia Pastoris. Appl. Biochem. Biotechnol. 2009, 158:432-444.
19. Lünsdorf H., Gurramkonda C., Adnan A., Khanna N., Rinas U. Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen. Microb. Cell Fact. 2011, 10:48.
20. Malkin A.J., Plomp M., McPherson A. Unraveling the architecture of viruses by high-resolution atomic force microscopy. Methods Mol. Biol. 2005, 292:85-108.
21. Milhiet P.E., Dosset P., Godefroy C., Le G.C., Guigner J.M., Larquet E., Ronzon F., Manin C. Nanoscale topography of hepatitis B antigen particles by atomic force microscopy. Biochimie 2011, 93:254-259.
22. Milich D.R., Thornton G.B., Neurath A.R., Kent S.B., Michel M.L., Tiollais P., Chisari F.V. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 1985, 228:1195-1199.
23. Ottone S., Nguyen X., Bazin J., Bérard C., Jimenez S., Letourneur O. Expression of hepatitis B surface antigen major subtypes in Pichia pastoris and purification for in vitro diagnosis. Protein Expr. Purif. 2007, 56:177-188.
24. Romanos M.A., Scorer C.A., Clare J.J. Foreign gene expression in yeast: a review. Yeast 1992, 8:423-488.
25. Shepard C.W., Simard E.P., Finelli L., Fiore A.E., Bell B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol. Rev. 2006, 28:112-125.
26. Shouval D., Ilan Y., Adler R., Deepan R., Panet A., Even-Chen Z. Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines. Vaccine 1994, 12:1453-1459.
27. Valenzuela P., Medina A., Rutter W.J., Ammerer G., Hall B.D. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 1982, 298:347-350.
28. Vassileva A., Chugh D.A., Swaminathan S., Khanna N. Effect of copy number on the expression levels of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris. Protein Expr. Purif. 2001, 21:71-80.
29. Yamada T., Iwabuki H., Kanno T., Tanaka H., Kawai T., Fukuda H., Kondo A., Seno M., Tanizawa K., Kuroda S. Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1-pre-S2- S) protein. Vaccine 2001, 19:3154-3163.
30. Yap I., Guan R., Chan S.H. Recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein - a preliminary study on immunogenicity. Vaccine 1992, 10:439-442.
31. Yap I., Guan R., Chan S.H. Study on the comparative immunogenicity of a recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein with non pre-S containing vaccines. J. Gastroenterol. Hepatol. 1995, 10:51-55.
32. Zuckerman J.N., Sabin C., Craig F.M., Williams A., Zuckerman A.J. Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study. BMJ 1997, 314:329-333.